Enanta Pharmaceuticals Announces Submission of EU Marketing Authorization Applications to the European Medicines Agency for All-Oral, Interferon-Free Hepatitis C Regimen Containing ABT-450

[Business Wire] – Enanta Pharmaceuticals, Inc. , a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, tod more

View todays social media effects on ENTA

View the latest stocks trending across Twitter. Click to view dashboard

See who Enanta is hiring next, click here to view